icon-folder.gif   Conference Reports for NATAP  
  EASL 2024
June 5-8, Milan, Italy
Back grey_arrow_rt.gif
Bulevirtide efficacy and safety in chronic hepatitis D patients on liver transplant waiting list for decompensated cirrhosis and/or hepatocellular carcinoma
  EASL 2024 June 5-8 Milan Italy
M.Meszaros 1, MN Hilleret 2,J. Dumortier 3, L. D'Alteroche 4, A. Abergel 5, M. Latournerie 6, T.Antonini 7, F. Conti 8, P. Borentain 9, S. Dharancy 10, GP Pageaux 1 1 Liver Transplant and Hepatogastroenterology Unit, CHU Montpellier, France, 2 Hepato-Gastroenterology Unit, CHU Grenoble Alpes, France; 3 Liver Transplant Unit, Digestive Diseases Federation, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Lyon, France 4.Hepatogastroenterology Unit, CHU Tours, France 5. Hepatogastroenterology Unit, CHU Estaing Clermont-Ferrand, France 6. Hepatogastroenterology Unit , CHU Dijon,, France 7. Hepatology Unit, Hôpital de la Croix-Rousse, Lyon, France 8.Hepatology Unit, Pitié Salpetriere , Assistance Publique-Hôpitaux de Paris, France 9. Hepatogastroenterology Unit, CHU Timone, Marseille, France 10.CHRU Lille, Hepatology Unit, Claude Huriez Hospital, CHRU Lille, Lille, France